Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 2/20 | 0.56 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.56 |
| ▸ | DHFR | P00374 | 2/20 | 0.49 |
| ▸ | P2RY10 | O00398 | 8/20 | 0.47 |
| ▸ | GPR34 | Q9UPC5 | 5/20 | 0.47 |
| ▸ | GPR174 | Q9BXC1 | 5/20 | 0.46 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.46 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.46 |
| ▸ | PPARD | Q03181 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16673226 | 0.84 | CYP4F2 (0.67) | CYP4F2CYP4A11DHFRALDH1A1GAA | |
| SCHEMBL4281161 | 0.82 | CYP4F2 (0.56) | CYP4F2CYP4A11DHFRP2RY10GPR34 | |
| SCHEMBL16972794 | 0.80 | CYP4F2 (0.60) | CYP4F2CYP4A11DHFRPPARDALDH1A1 | |
| SCHEMBL16673056 | 0.79 | CYP4F2 (0.62) | CYP4F2CYP4A11DHFRLTB4RLTB4R2 | |
| SCHEMBL7687145 | 0.79 | CYP4F2 (0.67) | CYP4F2CYP4A11ALDH1A1GAA | |
| SCHEMBL17670843 | 0.78 | CYP4F2 (0.66) | CYP4F2CYP4A11DHFRLTB4RLTB4R2 | |
| SCHEMBL2956872 | 0.78 | CYP4F2 (0.58) | CYP4F2CYP4A11P2RY10ALDH1A1GAA | |
| SCHEMBL13860058 | 0.78 | CYP4F2 (0.58) | CYP4F2CYP4A11ALDH1A1GAA | |
| SCHEMBL10741672 | 0.78 | CYP4F2 (0.65) | CYP4F2CYP4A11DHFR | |
| SCHEMBL16672611 | 0.78 | CYP4F2 (0.69) | CYP4F2CYP4A11DHFRLTB4RLTB4R2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0544488-B1 | Substituted phenyl phenol leukotriene antagonists | LILLY CO ELI (US) | 1998-03-11 | — | — | EP | disclosed |
| CN-1035001-C | Substituted phenyl phenol leukotriene antagonists | LILLY CO ELI (US) | 1997-05-28 | — | — | CN | disclosed |
| WO-1996036347-A1 | USE OF LEUKOTRIENE ANTAGONISTS FOR ALZHEIMER'S DISEASE | ELI LILLY AND COMPANY (US) | 1996-11-21 | — | — | WO | disclosed |
| EP-0743064-A1 | Leukotriene antagonists for use in the treatment or prevention of alzheimer's disease | ELI LILLY AND COMPANY (US) | 1996-11-20 | — | — | EP | disclosed |
| US-5462954-A | Antiinflammatory, antiallergens; treating asthma | ELI LILLY AND COMPANY (US) | 1995-10-31 | — | — | US | disclosed |
| CN-1088906-A | The phenyl phenol leukotriene antagonists that replaces | LILLY CO ELI (US) | 1994-07-06 | — | — | CN | disclosed |
| EP-0544488-A2 | Substituted phenyl phenol leukotriene antagonists | ELI LILLY AND COMPANY (US) | 1993-06-02 | — | — | EP | disclosed |